000277883 001__ 277883
000277883 005__ 20250504001132.0
000277883 0247_ $$2doi$$a10.1038/s41531-025-00885-5
000277883 0247_ $$2pmid$$apmid:40180909
000277883 0247_ $$2pmc$$apmc:PMC11968880
000277883 0247_ $$2altmetric$$aaltmetric:175822277
000277883 037__ $$aDZNE-2025-00503
000277883 041__ $$aEnglish
000277883 082__ $$a610
000277883 1001_ $$0P:(DE-2719)2811747$$aBedarf, Janis$$b0$$eFirst author
000277883 245__ $$aA prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson's Disease.
000277883 260__ $$a[London]$$bSpringer Nature$$c2025
000277883 3367_ $$2DRIVER$$aarticle
000277883 3367_ $$2DataCite$$aOutput Types/Journal article
000277883 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1745915661_11441
000277883 3367_ $$2BibTeX$$aARTICLE
000277883 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000277883 3367_ $$00$$2EndNote$$aJournal Article
000277883 520__ $$aCurrent treatment of Parkinson's Disease (PD) remains symptomatic, and disease-modifying approaches are urgently required. A promising approach is to modify intestinal microbiota and key metabolites of bacterial fermentation: short-chain fatty acids (SCFA), which are decreased in PD. A prospective, controlled pilot study (DRKS00034528) was conducted on 11 couples (PD patient plus healthy spouse as control (CO)). Participants followed a 4-week diet rich in dietary fibre, including intake of the prebiotic Lactulose. Gut metagenomes, faecal and urinary metabolites, and clinical characteristics were assessed. The dietary intervention significantly augmented faecal SCFA and increased Bifidobacteria spp., reducing PD-related gastrointestinal symptoms. The pre-existing bacterial dysbiosis in PD (depletion of Blautia, Dorea, Erysipelatoclostridium) persisted. Bacterial metabolite composition in faeces and urine positively changed with the intervention: Brain-relevant gut metabolic functions involved in neuroprotective and antioxidant pathways, including S-adenosyl methionine, glutathione, and inositol, improved in PD. These promising results warrant further investigation in larger cohorts.
000277883 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000277883 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000277883 7001_ $$00000-0002-7600-1953$$aRomano, Stefano$$b1
000277883 7001_ $$aHeinzmann, Silke Sophie$$b2
000277883 7001_ $$00000-0002-3849-9527$$aDuncan, Anthony$$b3
000277883 7001_ $$aTraka, Maria H$$b4
000277883 7001_ $$aNg, Duncan$$b5
000277883 7001_ $$aSegovia-Lizano, Daniella$$b6
000277883 7001_ $$aSimon, Marie-Christine$$b7
000277883 7001_ $$aNarbad, Arjan$$b8
000277883 7001_ $$0P:(DE-2719)2000056$$aWüllner, Ullrich$$b9$$udzne
000277883 7001_ $$aHildebrand, Falk$$b10
000277883 773__ $$0PERI:(DE-600)2819218-7$$a10.1038/s41531-025-00885-5$$gVol. 11, no. 1, p. 66$$n1$$p66$$tnpj Parkinson's Disease$$v11$$x2373-8057$$y2025
000277883 8564_ $$uhttps://pub.dzne.de/record/277883/files/DZNE-2025-00503%20SUP.pdf
000277883 8564_ $$uhttps://pub.dzne.de/record/277883/files/DZNE-2025-00503.pdf$$yOpenAccess
000277883 8564_ $$uhttps://pub.dzne.de/record/277883/files/DZNE-2025-00503%20SUP.pdf?subformat=pdfa$$xpdfa
000277883 8564_ $$uhttps://pub.dzne.de/record/277883/files/DZNE-2025-00503.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000277883 909CO $$ooai:pub.dzne.de:277883$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000277883 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811747$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000277883 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000056$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000277883 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000277883 9141_ $$y2025
000277883 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-11
000277883 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-11
000277883 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-11
000277883 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000277883 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNPJ PARKINSONS DIS : 2022$$d2024-12-11
000277883 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:43:48Z
000277883 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:43:48Z
000277883 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-11
000277883 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-11
000277883 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-11
000277883 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000277883 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:43:48Z
000277883 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-11
000277883 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNPJ PARKINSONS DIS : 2022$$d2024-12-11
000277883 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-11
000277883 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-11
000277883 9201_ $$0I:(DE-2719)1011302$$kAG Wüllner$$lBiomarker Parkinson's Disease$$x0
000277883 980__ $$ajournal
000277883 980__ $$aVDB
000277883 980__ $$aUNRESTRICTED
000277883 980__ $$aI:(DE-2719)1011302
000277883 9801_ $$aFullTexts